Dominique Salmon

9.0k total citations · 2 hit papers
147 papers, 4.7k citations indexed

About

Dominique Salmon is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Dominique Salmon has authored 147 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 60 papers in Infectious Diseases and 34 papers in Hepatology. Recurrent topics in Dominique Salmon's work include Hepatitis C virus research (32 papers), HIV Research and Treatment (29 papers) and HIV-related health complications and treatments (25 papers). Dominique Salmon is often cited by papers focused on Hepatitis C virus research (32 papers), HIV Research and Treatment (29 papers) and HIV-related health complications and treatments (25 papers). Dominique Salmon collaborates with scholars based in France, Netherlands and United States. Dominique Salmon's co-authors include Dominique Costagliola, Geneviève Chêne, Fabrice Bonnet, Thierry May, Philippe Morlat, Charlotte Lewden, Florence Tubach, Éric Jougla, Philippe Ravaud and P. Cacoub and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Dominique Salmon

133 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma

1999 550 citations Dominique Salmon et al. profile →
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

2009 460 citations Florence Tubach, Dominique Salmon et al. profile →

Peers

Countries citing papers authored by Dominique Salmon

Since Specialization

Citations

This map shows the geographic impact of Dominique Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Salmon more than expected).

Fields of papers citing papers by Dominique Salmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Salmon. The network helps show where Dominique Salmon may publish in the future.

Co-authorship network of co-authors of Dominique Salmon

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Salmon. A scholar is included among the top collaborators of Dominique Salmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Salmon. Dominique Salmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inflammation‐, immunothrombosis,‐ and autoimmune‐feedback loops may lead to persistent neutrophil self‐stimulation in long COVID 2024 ·Journal of Medical Virology ·Alain R. Thierry, Dominique Salmon	4
2	Patients with Long COVID continue to experience significant symptoms at 12 months and factors associated with improvement: A prospective cohort study in France (PERSICOR) 2023 ·International Journal of Infectious Diseases ·Dominique Salmon, Dorsaf Slama, (unknown), (unknown), (unknown), (unknown), Pauline Oustric, (unknown), Patricia Thoreux, (unknown)	11
3	Direct, indirect and total effect of HIV coinfection on the risk of non‐liver‐related cancer in hepatitis C virus‐infected patients treated by direct‐acting antivirals: a mediation analysis 2021 ·HIV Medicine ·(unknown), Stanislas Pol, Philippe Sogni, Hélène Fontaine, Karine Lacombe, Jean‐Marc Lacombe, (unknown), Céline Dorival, Marc Bourlière, Firouzé Bani‐Sadr, Victor de Lédinghen, David Zucman, Dominique Larrey, Dominique Salmon, Fabrice Carrat, Linda Wittkop, (unknown), (unknown)	1
4	Risk of severe clinical events after sustained virological response following direct‐acting antiviral therapy in HIV and hepatitis C virus coinfected participants 2021 ·HIV Medicine ·(unknown), Linda Wittkop, Firouzé Bani‐Sadr, Karine Lacombe, (unknown), Camille Gilbert, Patrick Miailhes, David Zucman, Marc Antoine Valantin, (unknown), Philippe Morlat, Eric Billaud, Lionel Piroth, Alissa Naqvi, Philippe Sogni, Dominique Salmon, (unknown)	3
5	Répartition des secteurs professionnels à risque d’exposition chez les cas de leptospirose diagnostiqués en France entre 2007 et 2017 2020 ·Archives des maladies professionnelles et de médecine du travail/Archives des maladies professionnelles et de l'environnement ·(unknown), Patrice Bourée, Dominique Salmon	1
6	Prevalence of Silent Atherosclerosis and Other Comorbidities in an Outpatient Cohort of Adults Living with HIV: Associations with HIV Parameters and Biomarkers 2020 ·AIDS Research and Human Retroviruses ·Jade Ghosn, Hendy Abdoul, Soraya Fellahi, (unknown), Dominique Salmon, Jean‐Pierre Morini, Jean‐François Deleuze, Jacques Blacher, J. Capeau, Jean‐Philippe Bastard, Jean‐Paul Viard	4
7	Prognostic factors of survival in HIV/HCV co‐infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort 2018 ·Liver International ·Moana Gelu‐Siméon, M. Lewin, Maria A. Ostos, (unknown), (unknown), Elina Teicher, Richard Layese, Françoise Roudot‐Thoraval, Hélène Fontaine, Rodolphe Sobesky, Dominique Salmon, Didier Samuel, Olivier Séror, Pierre Nahon, Laurence Meyer, Jean‐Charles Duclos‐Vallée, (unknown)	11
8	Impact of Sequential Culture Results on Diagnosis and De-Escalation of the Antibiotic Regimen in Joint and Bone Infections 2017 ·Surgical Infections ·Solen Kernéis, (unknown), (unknown), L. Eyrolle, Philippe Leclerc, Hélène Poupet, Julien Loubinoux, R. Gauzit, Dominique Salmon, Odile Launay, Claire Poyart, Philippe Anract, P Morand	1
9	Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial 2016 ·AIDS Research and Human Retroviruses ·Valérie Pourcher, Aude Desnoyer, Lambert Assoumou, Célèste Lebbé, (unknown), Anne‐Geneviève Marcelin, (unknown), Séverine Gibowski, Dominique Salmon, Jean-Marie Chennebault, Isabelle Poizot‐Martin, Gilles Peytavin, François Boué, Dominique Costagliola, (unknown)	24
10	Triple therapy with boceprevir or telaprevir in a E uropean cohort of cirrhotic HIV / HCV genotype 1‐coinfected patients 2015 ·Liver International ·Patrick Miailhes, Camille Gilbert, Karine Lacombe, Joop E. Arends, Massimo Puoti, Jürgen K. Rockstroh, Philippe Sogni, Hélène Fontaine, Éric Rosenthal, María Winnock, (unknown), Linda Wittkop, François Dabis, Dominique Salmon, (unknown)	5
11	Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections 2015 ·Infection ·Emmanuel Curis, Vincent Pestre, Vincent Jullien, L. Eyrolle, (unknown), P Morand, (unknown), (unknown), (unknown), Valérie Dumaine, (unknown), A. Babinet, Philippe Anract, Dominique Salmon	33
12	Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir) 2011 ·Clinics and Research in Hepatology and Gastroenterology ·Valérie Bourcier, María Winnock, (unknown), (unknown), Élodie Pambrun, Isabelle Poizot‐Martin, Cendrine Chaffaut, Sylvie Chevret, Jean–Claude Trinchet, Dominique Salmon	33
13	Encrusting Cystitis Due to Corynebacterium urealyticum in a Patient with ANCA-Associated Vasculitis: Case Report and Review of the Literature 2011 ·Seminars in Arthritis and Rheumatism ·Christian Pagnoux, A. Bérezné, R. Damade, (unknown), Jessie Aouizerate, Véronique Le Guern, Dominique Salmon, Loı̈c Guillevin	17
14	Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study 2010 ·Arthritis Research & Therapy ·Mélanie Gilson, Laure Gossec, Xavier Mariette, (unknown), Marie-Hélène Guyot, Jean‐Marie Berthelot, Daniel Wendling, C. Michelet, P. Dellamonica, Florence Tubach, Maxime Dougados, Dominique Salmon	46
15	Changes in Cancer Mortality among HIV‐Infected Patients: The Mortalité 2005 Survey 2009 ·Clinical Infectious Diseases ·Fabrice Bonnet, Christine Burty, Charlotte Lewden, Dominique Costagliola, Thierry May, Vincent Bouteloup, Éric Rosenthal, Éric Jougla, P. Cacoub, Dominique Salmon, Geneviève Chêne, Philippe Morlat, (unknown)	122
16	Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic) 2008 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Charlotte Lewden, Thierry May, Éric Rosenthal, Christine Burty, Fabrice Bonnet, Dominique Costagliola, Éric Jougla, Caroline Semaille, Philippe Morlat, Dominique Salmon, P. Cacoub, Geneviève Chêne	268
17	Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment 2008 ·Clinical Microbiology and Infection ·Bernard Denis, A. Lefort, René‐Marc Flipo, Florence Tubach, Marc Lémann, Philippe Ravaud, Dominique Salmon, Xavier Mariette, Olivier Lortholary	34
18	New CD4 ⁺ and CD8 ⁺ T Cell Responses Induced in Chronically HIV Type-1-Infected Patients After Immunizations with an HIV Type 1 Lipopeptide Vaccine 2006 ·AIDS Research and Human Retroviruses ·Hanne Gahéry, (unknown), Bénédicte Charmeteau, (unknown), Angéla Jackson, Muriel Andrieu, Jeannine Choppin, Dominique Salmon, Gilles Pialoux, Jean‐Gérard Guillet	44
19	Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults 2006 ·AIDS ·Christine Durier, Odile Launay, Vincent Meiffrédy, Yacine Saïdi, Dominique Salmon, Yves Lévy, Jean‐Gérard Guillet, Gilles Pialoux, J Aboulker	49
20	Resting energy expenditure is increased in stable, malnourished HIV-infected patients 1991 ·American Journal of Clinical Nutrition ·J.C. Melchior, Dominique Salmon, D Rigaud, C Leport, E. Bouvet, (unknown), (unknown), François Vachon, J P Coulaud, M Apfelbaum	152

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact